iSpecimen Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	9.27	9.93	10.4	11.14	8.18	4.3
Revenue Growth (YoY)	-14.45%	-4.56%	-6.58%	36.06%	90.40%	-
Cost of Revenue	4.67	4.82	4.76	5.25	3.59	2.13
Gross Profit	4.59	5.11	5.65	5.89	4.6	2.17
Selling, General & Admin	9.9	9.89	10.38	8.04	4.18	3.35
Research & Development	3.64	3.57	2.66	1.84	1.47	0.99
Other Operating Expenses	2.68	2.82	2.8	1.98	-0.89	1.71
Operating Expenses	16.22	16.28	15.83	11.86	4.76	6.05
Operating Income	-11.63	-11.17	-10.19	-5.97	-0.16	-3.88
Interest Expense / Income	0.02	0.02	0.24	2.1	2.1	1.72
Other Expense / Income	-0.07	-0.09	-0.18	0.89	2.39	-0.72
Pretax Income	-11.57	-11.1	-10.25	-8.96	-4.65	-4.88
Income Tax	0	0	0	0	0	-0.16
Net Income	-11.57	-11.1	-10.25	-8.96	-4.65	-4.73
Shares Outstanding (Basic)	9	9	9	4	1	1
Shares Outstanding (Diluted)	9	9	9	4	1	1
Shares Change	1.69%	2.23%	106.28%	357.95%	0.01%	-
EPS (Basic)	-1.28	-1.23	-1.16	-2.09	-4.97	-5.05
EPS (Diluted)	-1.28	-1.23	-1.16	-2.09	-4.97	-5.05
Free Cash Flow	-8.54	-10.55	-9.01	-11.71	-1.39	-4.16
Free Cash Flow Per Share	-0.94	-1.17	-1.02	-2.73	-1.49	-4.44
Gross Margin	49.58%	51.45%	54.27%	52.86%	56.19%	50.49%
Operating Margin	-125.46%	-112.50%	-97.92%	-53.61%	-1.96%	-90.27%
Profit Margin	-124.84%	-111.80%	-98.50%	-80.48%	-56.84%	-109.97%
Free Cash Flow Margin	-92.10%	-106.28%	-86.60%	-105.13%	-17.00%	-96.67%
EBITDA	-9.41	-9.02	-8.8	-5.86	-1.74	-2.52
EBITDA Margin	-101.54%	-90.83%	-84.61%	-52.58%	-21.21%	-58.73%
Depreciation & Amortization	2.14	2.07	1.21	1	0.82	0.63
EBIT	-11.55	-11.08	-10.01	-6.86	-2.56	-3.16
EBIT Margin	-124.65%	-111.64%	-96.20%	-61.60%	-31.22%	-73.51%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).